Rockwell Medical (RMTI) Change in Accured Expenses (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Change in Accured Expenses came in at -$1.5 million in Q1 2026, up 11.97% YoY from -$1.3 million in Q1 2025, and down 334.08% on a QoQ basis from $625000.0 in Q4 2025.
Rockwell Medical (RMTI) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Change in Accured Expenses data on file, last reported at -$1.5 million in Q1 2026.
- Quarterly Change in Accured Expenses rose 11.97% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (down 95.25% YoY) and the FY2025 annual result came in at -$1.7 million, down 62.38% from the prior year.
- Change in Accured Expenses slipped to -$1.5 million in Q1 2026, from $625000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $2.9 million in Q3 2023 to a low of -$3.3 million in Q1 2023.
- A 5-year average of -$118705.9 and a median of -$139000.0 in 2025 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses tumbled 414.84% — and 2025, when it soared 320.85%.
- Tracing RMTI's Change in Accured Expenses over 5 years: stood at $1.8 million in 2022, then plunged by 63.05% to $657000.0 in 2023, then plunged by 143.07% to -$283000.0 in 2024, then soared by 320.85% to $625000.0 in 2025, then sank by 334.08% to -$1.5 million in 2026.
- The last three Change in Accured Expenses figures came in at -$1.5 million (Q1 2026), $625000.0 (Q4 2025), and -$139000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Mn |
| Jun 30, 2026 | 1.10 Mn |
| Mar 31, 2026 | -1.46 Mn |
| Mar 31, 2026 | -1.46 Mn |
| Dec 31, 2025 | 625,000.00 |
| Dec 31, 2025 | 625,000.00 |
| Sep 30, 2025 | -139,000.00 |
| Sep 30, 2025 | -139,000.00 |
| Jun 30, 2025 | -503,000.00 |
| Jun 30, 2025 | -503,000.00 |
| Mar 31, 2025 | -1.66 Mn |
| Mar 31, 2025 | -1.66 Mn |
| Dec 31, 2024 | -283,000.00 |
| Dec 31, 2024 | -283,000.00 |
| Sep 30, 2024 | 347,000.00 |
| Sep 30, 2024 | 347,000.00 |
| Jun 30, 2024 | 840,000.00 |
| Jun 30, 2024 | 840,000.00 |
| Mar 31, 2024 | -1.94 Mn |
| Mar 31, 2024 | -1.94 Mn |